[HTML][HTML] Nanoparticles in the new era of cardiovascular therapeutics: challenges and opportunities
P Yang, J Ren, L Yang - International journal of molecular sciences, 2023 - mdpi.com
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide.
Although a cadre of therapeutic strategies have been made available for CVDs in the clinical …
Although a cadre of therapeutic strategies have been made available for CVDs in the clinical …
Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities
P Yang, J Ren, L Yang - International journal of molecular …, 2023 - pubmed.ncbi.nlm.nih.gov
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide.
Although a cadre of therapeutic strategies have been made available for CVDs in the clinical …
Although a cadre of therapeutic strategies have been made available for CVDs in the clinical …
Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities
P Yang, J Ren, L Yang - International Journal of Molecular …, 2023 - search.proquest.com
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide.
Although a cadre of therapeutic strategies have been made available for CVDs in the clinical …
Although a cadre of therapeutic strategies have been made available for CVDs in the clinical …
[HTML][HTML] Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities
P Yang, J Ren, L Yang - International Journal of Molecular …, 2023 - ncbi.nlm.nih.gov
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide.
Although a cadre of therapeutic strategies have been made available for CVDs in the clinical …
Although a cadre of therapeutic strategies have been made available for CVDs in the clinical …
Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities.
P Yang, J Ren, L Yang - International Journal of Molecular Sciences, 2023 - europepmc.org
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide.
Although a cadre of therapeutic strategies have been made available for CVDs in the clinical …
Although a cadre of therapeutic strategies have been made available for CVDs in the clinical …
Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities.
P Yang, J Ren, L Yang - International Journal of Molecular …, 2023 - search.ebscohost.com
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide.
Although a cadre of therapeutic strategies have been made available for CVDs in the clinical …
Although a cadre of therapeutic strategies have been made available for CVDs in the clinical …
[引用][C] Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities
P Yang, J Ren, L Yang - Int. J. Mol. Sci, 2023 - europepmc.org
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide.
Although a cadre of therapeutic strategies have been made available for CVDs in the clinical …
Although a cadre of therapeutic strategies have been made available for CVDs in the clinical …
Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities
P Yang, J Ren, L Yang - International journal of molecular …, 2023 - pubmed.ncbi.nlm.nih.gov
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide.
Although a cadre of therapeutic strategies have been made available for CVDs in the clinical …
Although a cadre of therapeutic strategies have been made available for CVDs in the clinical …